Skip to main content
Download PDF

Factors associated with loss to follow up among HIV-exposed children: a historical cohort study from 2000 to 2017, in Porto Alegre, Brazil

BMC Public Health volume 22, Article number: 1422 (2022) Cite this article

Abstract

Background

There are many inequalities in terms of prevention and treatment for pregnant women with HIV and exposed children in low and middle-income countries. The Brazilian protocol for prenatal care includes rapid diagnostic testing for HIV, compulsory notification, and monitoring by the epidemiological surveillance of children exposed to HIV until 18 months after delivery. The case is closed after HIV serology results are obtained. Lost to follow-up is defined as a child who was not located at the end of the case, and, therefore, did not have a laboratory diagnosis. Lost to follow-up is a current problem and has been documented in other countries. This study analyzed factors associated with loss to follow-up among HIV-exposed children, including sociodemographic, behavioral, and health variables of mothers of children lost to follow-up.

Methods

This historical cohort study included information on mothers of children exposed to HIV, born in Porto Alegre, from 2000 to 2017. The research outcome was the classification at the end of the child's follow-up (lost to follow-up or not). Factors associated with loss to follow-up were investigated using the Poisson regression model. Relative Risk calculations were performed. The significance level of 5% was adopted for variables in the adjusted model.

Results

Of 6,836 children exposed to HIV, 1,763 (25.8%) were classified as lost to follow-up. The factors associated were: maternal age of up to 22 years (aRR 1.25, 95% CI: 1.09–1.43), the mother’s self-declared race/color being black or mixed (aRR 1.13, 95% CI: 1.03–1.25), up to three years of schooling (aRR 1.45, 95% CI: 1.26–1.67), between four and seven years of schooling (aRR 1.14, 95% CI: 1.02–1.28), intravenous drug use (aRR 1.29, 95% CI: 1.12–1.50), and HIV diagnosis during prenatal care or at delivery (aRR 1.37, 95% CI: 1.24–1.52).

Conclusion

Variables related to individual vulnerability, such as race, age, schooling, and variables related to social and programmatic vulnerability, remain central to reducing loss to follow-up among HIV-exposed children.

Peer Review reports

Background

Vertical HIV transmission in children can be avoided through prevention and treatment for pregnant women with HIV and exposed children [1, 2]. In 2020 85% [63%–98%] of pregnant women living with HIV had access to antiretroviral drugs to prevent transmission of HIV to their children [3]. This percentage, however, varies according to the weaknesses related to prenatal and postnatal care of health systems, especially in developing countries [4,5,6].

In Brazil, from 2000 to June 2020, 134,328 HIV-infected pregnant women were notified [7]. As for the rate of HIV detection in pregnant women, there was an increase of 21.7% over ten years: in 2009, 2.3 cases/thousand live births were registered, and, in 2019, this rate increased to 2.8 cases/thousand live births. Compared to other Brazilian state capitals, Porto Alegre, the location of this study, is the capital with the highest detection rate, with 17.6 cases/thousand live births recorded in 2019, a rate six times higher than the national rate. The AIDS detection rate in children under five years of age has been used as a proxy indicator for monitoring vertical HIV transmission. In 2019, this rate in Brazil was 1.9 cases/100,000 inhabitants. Porto Alegre is the fourth capital with the highest rate, with 7.2 cases/100,000 inhabitants [7].

Reducing the number of children infected with HIV and offering 95% treatment coverage is among the 95–95-95 goals that aim to prevent 5.9 million infections in children up to 15 years of age by 2030 [8]. Over the years, many actions have been documented in this area, especially in prenatal care, among which are the intensification of educational activities, the provision of rapid tests, the supply of antiretroviral therapy, and supplies of substitute inputs for breastfeeding [9,10,11,12]. Despite this, early diagnosis remains one of the main challenges [13,14,15]. The absence of a confirmatory test in children precludes the timely start of ART [16,17,18].

There are many inequalities prevention and treatment for pregnant women with HIV and exposed children in low and middle-income countries [6, 18,19,20,21]. In Brazil, ART is universally distributed by the public health system. Therefore, an epidemiological surveillance system with complete information on children exposed to HIV would significantly increase the ability to target services to those that need them.

The Brazilian protocol for prenatal care includes rapid diagnostic testing for HIV in the prenatal period with compulsory notification. Compulsory notification is a standardized document filled out during the pregnant woman’s visit when the HIV test result is positive. In the postnatal period, children exposed to HIV are monitored by epidemiological surveillance until 18 months after delivery [22]. The case is closed after HIV serology results are obtained. All this data is stored in a single database. Lost to follow-up is defined as a child who was not located at the end of the case and, therefore, did not have a laboratory diagnosis. Lost to follow-up is a current problem documented in other countries [18, 23,24,25,26].

In the city of Porto Alegre, approximately 400 children exposed to HIV are monitored annually. Case closure as lost to follow-up is not uncommon. Ignoring the HIV status of exposed children makes it impossible to start early interventions, contributing to infant morbidity and mortality [1, 27,28,29]. This study analyzed the factors associated with the children exposed to HIV being lost to follow-up (sociodemographic, behavioral, and health variables of mothers lost to follow). All sociodemographic and behavioral variables available in the National Surveillance System related to pregnant women living with HIV were investigated.

We believe that this analysis can contribute to developing more systematic monitoring strategies, strengthening epidemiological surveillance in Porto Alegre, the Brazilian state capital with the highest rate of HIV detection in pregnant women.

Methodology

A historical cohort study was conducted in 2021. We extracted data from a national registry system from 2000 to 2017, characterizing the follow-up period.

Population

The study uses a national database with information on pregnant women living with HIV and children exposed to HIV who were born in Porto Alegre. In the study scenario, the investigation of the child’s exposure to HIV ends up to 24 months after birth. This historical cohort study included information on pregnant women living with HIV and the outcome of the child’s exposure to HIV. For diagnosis in children under 18 months of age, the following tests are available: molecular test to quantify HIV-RNA/HIV viral load (CV-HIV) and detect HIV proviral DNA. The first CV-HIV collection must be performed immediately after birth. Any test whose result shows detectable CV-HIV, regardless of the viremia value, will require an immediate CV-HIV collection. The second test, if the first CV-HIV is undetectable, will be collected at 14 days of age. Unconfirmed cases should continue under investigation, with CV-HIV collections at two and eight weeks after the end of antiretroviral prophylaxis. An anti-HIV test should be performed at 12 months and, if positive, repeated at 18 months. In children with CV-HIV below 5,000 copies/mL or discordant results, proviral DNA, which has high specificity, should be used. The child will be considered HIV-infected if there are two detectable CV-HIV results above 5,000 copies/mL or positive proviral DNA [30].

In Porto Alegre, the deadline for closing the case runs from 18 to 24 months. The child is considered lost to follow-up at 24 months of follow-up without the completion of the laboratory diagnosis when the case is closed [31]. The unavailability of information is usually due to the lack of health care for the child in health units, at an age in which children should get regular check-ups.

Data collection and variables

The epidemiological surveillance service is responsible for registering the information of pregnant women living with HIV, as well as monitoring and updating the health outcome of children exposed to HIV. In Brazil, such data are stored in a system called “Notifiable Diseases Information System” (SINAN), fed by compulsory notification. The database made available by the epidemiological surveillance service included all children exposed to HIV notified in the city of Porto Alegre with their respective updated results.The research data were collected by two trained researchers, during a six-month period in the year 2020, directly from SINAN. There were cases with missing information on race/color. To look for this information, other information systems that are used for medical records were accessed, such as the Laboratory Examination Control System (SISCEL), the Logistic Control System for Medicines (SICLOM), the electronic medical record of the primary care user (E-SUS) and the SUS User Registration System (CADSUS). The sociodemographic data presented refer to pregnant women at the time they were notified of HIV by the health services. Sociodemographic (age, race/color, and schooling), behavioral (lifetime injecting drug use), and health-related (time of HIV diagnosis, beginning of prenatal care, and use of ART during childbirth) information of pregnant women were all collected in the system in order to analyze possible associated factors (independent variables). The outcome of the child’s exposure was obtained using the same system (move to a different city, death, abortion, HIV positive, HIV negative, or lost to follow-up). Cases the pregnancy resulted in abortion, cases the children died within 24 months of follow-up, and cases moved to a different city were excluded because they did not complete the follow-up. The dependent variable was lost to follow-up. In terms of the variables, schooling was categorized as “up to three” years of study (including women who never attended school), “between four and seven” years of study, and “eight years or more” years of study. The information on the moment of HIV diagnosis for the pregnant woman was already grouped in the original data into two categories: (i) before prenatal care, or (ii) during prenatal care or at delivery. This was therefore used with these two categories in the statistical analysis.

The study’s outcome was the closure status of children exposed to HIV (yes or not) cases. Lost to follow-up is defined as a child who was not located at the end of the case, and, therefore, did not have a laboratory diagnosis.

Statistical analysis

Statistical analysis was performed using SPSS Software, version 22.0. Absolute numbers and frequencies were used for sample description. Comparisons were made either using the homogeneity of proportions test based on Pearson’s or Fisher’s chi-square statistics and standardized residuals. The level of significance adopted was 5%.

The association between predictors and the child’s outcome as a loss to follow-up was investigated using the Poisson regression model. Relative Risk calculations were performed in unadjusted and adjusted models. The level of significance used was p < 0.20 in the unadjusted model for insertion of variables in the adjusted model. The significance level of 5% was adopted for variables in the adjusted model. P-values of the models were derived from the Wald test.

Results

Between 2000 and 2017, 8,190 children exposed to mother-to-child transmission of HIV during pregnancy were notified. These cases formed the original health surveillance database. Of these, in 520 cases the pregnancy resulted in abortion, in 212 cases the children died within 24 months of follow-up, and in 622 cases moved to a different city where it was not possible to complete the follow-up. Thus, the total for this analysis was 6,836 cases, which corresponded to cases classified as HIV positive, HIV negative, or lost to follow-up. Of the 6,836 cases, 1,763 (25.8%) children were classified as lost to follow-up.

Regarding the completeness of data, there were 928 cases with missing information on race/color. After searching for the information in various medical record systems, 217 cases still had missing information on race/color.

Table 1 describes the characteristics of mothers of lost to follow up. The proportions of mothers of children lost to follow-up differ across age categories (p < 0.001). The mothers of children classified as “lost to follow-up” are younger. Regarding race/color, there is a higher percentage of women declaring themselves to be black or mixed in the lost to follow-up group (p = 0.001). There is a significant difference in schooling between groups (p < 0.001). Pregnant women with up to three years of schooling were more frequent in the lost to follow-up group. Intravenous drug use was more prevalent in the lost to follow-up group (p = 0.003). Among women who were HIV diagnosed during prenatal care or at delivery, 34.7% were lost to follow-up, while among those diagnosed before prenatal care, 24% resulted in lost to follow-up (p < 0.001). The variable Partner with HIV showed almost 40% loss, so it was not considered for the modeling of associated factors.

Table 1 Demographic, behavioral, and health profile of mothers of HIV-exposed children who were lost to follow-up notified to SINAN, in Porto Alegre, according to the outcome lost to follow-up, 2000 – 2017
Full size table

Table 2 presents the results of the non-adjusted models and adjusted models age, race/Color, schooling, intravenous drug use, and time of HIV diagnosis. The following socioeconomic, behavioral, and health factors of the studied mothers were associated with lost to follow-up in the final model: being up to 22 years of age (aRR 1.25; 95% CI 1.09–1.43); being self-declared as black or mixed (aRR 1.13; 95% CI 1.03–1.25); up to three years of study (aRR 1.45; 95% CI 1.26–1.67); from four to seven years of study (aRR 1.14; 95% CI 1.02–1.28); intravenous drug use (aRR 1.29; 95% CI 1.12–1.50); and HIV diagnosis during prenatal care (aRR 1.37; 95% CI 1.24–1.52).

Table 2 Factors associated with lost to follow-up of children exposed to HIV in Porto Alegre, 2000—2017
Full size table

Discussion

This study demonstrates the importance of a public database to improve the monitoring of exposed children in a public policy to prevent HIV. The lack of information on the serology status of exposed children within the health care system can impact the planning and implementation of HIV prevention and care [18, 32, 33]. Our data indicate that the epidemiological surveillance system in Porto Alegre is unaware of the diagnosis of about a quarter of the children exposed to HIV. The absence of data also implies possible distortions in the rate of mother-to-child transmission of HIV, as many children considered to have been lost to follow-up may have had a positive result.

This is a problem that affects not only Brazil but also other countries that often have higher rates of loss to follow-up of children exposed to HIV [14, 21, 34, 35]. In a systematic review with meta-analysis [36], the estimated loss of follow-up of children exposed to HIV in 11 Sub-Saharan African countries was 33.9% (95% CI 27.6%-41.5%) in the three-month postpartum period. This study showed that there was little research in Sub-Saharan Africa that included a longer follow-up period. Two of them followed children for 12 months, with lost to follow-up of 50.2% [37] and 85.1% [38]. Other surveillance services that investigated children exposed to HIV for 18 months showed that the loss to follow-up ranged from 20.8 [39] to 66.1% [40]. In a recent study that analyzed the follow-up of children exposed to HIV at a referral hospital in Uganda, the percentage of lost to follow-up was 48% in 18 months [4].

Our data indicate that the loss to follow-up of children exposed to HIV is associated with the different dimensions of the vulnerability of pregnant women with HIV [41]. In the individual dimension, there is intravenous drug use; in the social dimension, being under 26 years of age, being black or mixed and having up to seven years of study; and in the programmatic dimension, the diagnosis of HIV during prenatal care or at delivery. This last result indicates that women with HIV enter the health service later [42, 43].

In the individual dimension, drug use appears to be associated with lower adherence to care for the prevention and treatment of HIV [44, 45]. In addition to the effects of the substances used, marginalization and stigma related to drug use and HIV itself are factors that interfere with access to and adherence to treatment [46]. In this sense, we emphasize that harm reduction strategies [47] could improve care, avoiding loss of follow-up. Care and social support interventions for drug users have shown better standards of care and adherence to drugs [48, 49].

In the social dimension, children whose mothers were up to 22 years old were at an excess risk of 25%, when compared to children of mothers over 32. Age may be interconnected with other factors, such as low socioeconomic status, lower education, and knowledge about HIV [50]. Regarding race/color, black or mixed women had a relative risk 13% higher to have children lost to follow-up. These data can be contextualized from the perspective of institutional racism [51, 52], which accentuates the inequality of access to health which has already been observed in the issue of race/color in Brazil in relation to HIV [7]. Regarding schooling, women with up to three years of schooling had a 45% excess risk of having children lost to follow-up. In the discussion on social vulnerability, education is an important element, as it represents possibilities for entering the labor market and has also been interpreted as an income proxy [53]. In a recent study in Mozambique, higher levels of schooling showed greater chances of having an early start of prenatal care [54]. This study was carried out in a scenario with cultural issues intertwined with the definition of roles associated with gender. We understand that younger women with less schooling may be financially dependent on their sexual partners, which would make the child more vulnerable to being lost to follow-up.

In the programmatic dimension, women diagnosed with HIV during the prenatal period or at delivery had an excess risk of 37% to have a child classified as lost to follow-up. In our study, the percentage of pregnant women who received the diagnosis in prenatal care or at delivery was high and was even greater in the loss to follow-up group (34.7% versus 24%). Barriers to HIV testing in primary care have been documented [55,56,57], so the possibility of HIV testing during prenatal care appears to be an opportunity to improve care.

This would be an alert for health professionals. The creation of a bond with pregnant women could prevent adverse health outcomes for the child. In fact, in a study carried out in Kenya, knowledge of the diagnosis before prenatal care proved to be a protective factor against loss to follow-up (OR 0.23; 95% CI 0.05–0.71) [18]. A study conducted in the United States found that women diagnosed with HIV during pregnancy are less likely to receive ART adequately during pregnancy and to obtain viral suppression after pregnancy [58].

In our study, the variable moment of diagnosis was divided into two strata: diagnosis during prenatal care or at delivery and diagnosis before prenatal care. Therefore, because the women who may have been diagnosed during prenatal care were grouped with those diagnosed at delivery, we do not know the actual number of women who were diagnosed at childbirth. This is a limitation of our study and is a critical issue to be discussed. Diagnosis at delivery may express the total absence of connection with primary care services or even the failure to perform an HIV test during prenatal care, a recommendation in force in a national protocol. A recent study discussed this issue in Brazil, showing that almost 20% of women in the state of Amazonas reached childbirth without knowing their HIV status, complementing another Brazilian study, in which 29% of women were not tested during prenatal care [59].

From a Brazilian public policy perspective, these results indicate primary care services' difficulty in identifying, linking, and retaining care for children exposed to HIV, problems also seen in other studies [10, 23, 26, 35, 36, 60,61,62,63]. In Brazil, primary care services monitor all newborns within their geographic areas of coverage [64]. In a review of access to services to prevent mother-to-child transmission of HIV, Hiarlaithe et al. (2014) identified the following access barriers: cost of traveling to the health service, secrecy in relation to diagnosis, the stigma surrounding HIV, and relationship with the partner [65]. In a study conducted in Ethiopia, it was found that the proportion of pregnant women who have comprehensive knowledge about preventing mother-to-child transmission of HIV was low [47]. The difficulty of access and level of knowledge was not investigated in this study, however, these issues may be related to loss to follow-up.

Like all scientific research, our study is not without limitations. The main one is that our study uses secondary databases, with the researcher having no control over the quality of data collected. However, we emphasize that we have used a greatly valued database by the surveillance team. In addition, the information was complemented by access to other health information systems. Therefore, we believe that this limitation has been reduced. Another limitation of the data already mentioned is the lack of HIV diagnosis during prenatal care or delivery, which prevented us from identifying the percentage of women diagnosed at each of these care moments.

Conclusion

When considering the sociodemographic, behavioral, and health characteristics of the mothers, we found that the factors associated with loss to follow-up in Porto Alegre are age, race/color, schooling, intravenous drug use, and time of HIV diagnosis. We recommend investing in integrated health information systems so that children exposed to HIV can be located within the health care system, thus reducing the number of losses to follow-up. We also recommend a particular focus on women using intravenous drugs, and the adoption of harm reduction actions, in order to avoid the loss to follow-up of exposed children.

Availability of data and materials

The datasets used and/or analyzed during the current study is available from the corresponding author upon reasonable request.

Abbreviations

ART:

Antiretroviral therapy

SINAN:

Notifiable Diseases Information System

SISCEL:

Laboratory Examination Control System

SICLOM:

Logistic Control System for Medicines

E-SUS:

Electronic medical record of the primary care user

CADSUS:

SUS User Registration System

References

  1. UNAIDS. Joint United Nations Programme for HIV/AIDS. Start Free Stay Free AIDS Free. report. Switzerland: Geneva; 2019. p. 96.

    Google Scholar 

  2. UNAIDS. Joint United Nations Programme for HIV/AIDS. Miles to go. Global AIDS update 2018. Switzerland: Geneva; 2018, p. 268.

  3. UNAIDS. Estatísticas UNAIDS. 2020.

    Google Scholar 

  4. Ankunda R, Cumber SN, Atuhaire C, et al. Loss to follow-up and associated maternal factors among HIV-exposed infants at the Mbarara Regional Referral Hospital, Uganda: a retrospective study. BMC Infect Dis. 2020;20(235):1–9.

    Google Scholar 

  5. Vrazo AC, Sullivan D, Ryan PB. Eliminating Mother-to-Child Transmission of HIV by 2030: 5 Strategies to Ensure Continued Progress. Glob Health Sci Pract. 2018;6(2):249–56.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Yaya S, Oladimeji O, Oladimeji KE, Bishwajit G. Prenatal care and uptake of HIV testing among pregnant women in Gambia: a cross-sectional study. BMC Public Health. 2021;20:485.

    Article  Google Scholar 

  7. BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Boletim Epidemiológico de HIV/Aids. Brasília: Ministério da Saúde; 2020. p. 68.

  8. UNAIDS. Joint United Nations Programme for HIV/AIDS. Global AIDS Update, 2020. Seizing the moment - Tackling entrenched inequalities to end epidemics. Switzerland: Geneva; 2020.

  9. Lockman S, Creek T. Acute Maternal HIV Infection during Pregnancy and Breast-Feeding: Substantial Risk to Infants. J Infec Dis. 2009;200(5):667–9.

    Article  Google Scholar 

  10. Saumu WM, Maleche-Obimbo E, Irimu G, Kumar R, Gichuhi C, Karau B. Predictors of loss to follow-up among children attending HIV clinic in a hospital in rural Kenya. Pan Afr Med J. 2019;32(216):1–8.

    Google Scholar 

  11. Andrews M-M, Storm DS, Burr CK, et al. Perinatal HIV Service Coordination: Closing Gaps in the HIV Care Continuum for Pregnant Women and Eliminating Perinatal HIV Transmission in the United States. Public Health Rep. 2018;133(5):532–42.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Transmission in the United States. 2022.

  13. Mohamed Y, Kupul M, Gare J, et al. Feasibility and acceptability of implementing early infant diagnosis of HIV in Papua New Guinea at the point of care: a qualitative exploration of health worker and key informant perspectives. BMJ Open. 2020;10(11):e043679.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kalawan V, Naidoo K, Archary M. Impact of routine birth early infant diagnosis on neonatal HIV treatment cascade in eThekwini district, South Africa. South Afr J HIV Med. 2020;21(1):1084.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Davies M-A, Pinto J. Targeting 90–90-90 - don’t leave children and adolescents behind. J Int AIDS Soc. 2015;18:20745.

    Article  PubMed  PubMed Central  Google Scholar 

  16. UNAIDS. Joint United Nations Programme for HIV/AIDS. Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive 2011–2015. Switzerland: Geneva; 2011.

  17. Idele P, Hayashi C, Porth T, Mamahit A, Mahy M. Prevention of Mother-to-Child Transmission of HIV and Paediatric HIV Care and Treatment Monitoring: From Measuring Process to Impact and Elimination of Mother-to-Child Transmission of HIV. AIDS Behav. 2017;21(1):23–33.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kigen HT, et al. Predictors of loss to follow up among HIV-exposed children within the prevention of mother to child transmission cascade, Kericho County, Kenya, 2016. Pan Afr Med J. 2018;30:178 p. 1–10.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Frey MT, Meaney-Delman D, Bowen V, et al. Surveillance for Emerging Threats to Pregnant Women and Infants. J Womens Health. 2009;28(8):1031–6.

    Article  Google Scholar 

  20. Melo GC de, Oliveira ECA de, Leal IB, et al. Spatial and temporal analysis of the Human Immunodeficiency Virus (HIV) in an area of social vulnerability in Northeast Brazil. Geospat Health. 2020;15(2). https://doi.org/10.4081/gh.2020.863.

  21. Mofenson LM, Cohn J, Sacks E. Challenges in the Early Infant HIV Diagnosis and Treatment Cascade. JAIDS. 2020;84(1):S1-4.

    PubMed  Google Scholar 

  22. BRASIL. Ministério da Saúde. SVS. Coordenação Geral de Desenvolvimento da Epidemiologia em Serviços. Guia de Vigilância em Saúde. Brasília: Ministério da Saúde, 2021. p. 126.

  23. Mpinganjira S, Tchereni T, Gunda A, Mwapasa V. Factors associated with loss-to-follow-up of HIV-positive mothers and their infants enrolled in HIV care clinic: A qualitative study. BMC Public Health. 2020;20(1):298.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Millar HC, Keter AK, Musick BS, et al. Decreasing incidence of pregnancy among HIV-positive adolescents in a large HIV treatment program in western Kenya between 2005 and 2017: a retrospective cohort study. Reprod Health. 2020;17(1):191.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Chandiwana N, Sawry S, Chersich M, Kachingwe E, Makhathini B, Fairlie L. High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa. Medicine. 2018;97(29):e10901.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Fisiha Kassa S, Zemene Worku W, Atalell KA, Agegnehu CD. Incidence of Loss to Follow-Up and Its Predictors Among Children with HIV on Antiretroviral Therapy at the University of Gondar Comprehensive Specialized Referral Hospital: A Retrospective Data Analysis. HIV AIDS (Auckl). 2020;12:525–33.

    Google Scholar 

  27. European Collaborative Study. CD4 Cell Response to Antiretroviral Therapy in Children with Vertically Acquired HIV Infection: Is It Associated with Age at Initiation? J Infect Dis. 2006;193(7):954–62.

    Article  Google Scholar 

  28. Dang LVP, Pham VH, Nguyen DM, et al. Elevation of immunoglobulin levels is associated with treatment failure in HIV-infected children in Vietnam. HIV AIDS (Auckl). 2018;11:1–7.

    Google Scholar 

  29. Guillén S, Prieto L, Jiménez de Ory S, et al. Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children. PLoS One. 2019;14(8):e0220552.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. BRASIL. Ministério da Saúde. SVS. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Coordenação-Geral de Vigilância do HIV/AIDS e das Hepatites Virais. Nota Informativa Nº 20/2020-CGAHV/DCCI/SVS/MS. Dispõe sobre atualizações nas recomendações de diagnóstico e tratamento de crianças vivendo com HIV acima de dois anos. 2020.

  31. BRASIL. Ministério da Saúde. Sistema de Informação de Agravos de Notificação. Ficha de Notificação/Investigação. Criança exposta ao HIV. 2009.

  32. Woldesenbet S, Jackson D, Lombard C, et al. Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE). PLoS ONE. 2015;10(7):e0132425.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Harris K, Yudin MH. HIV Infection in Pregnant Women: A 2020 Update. Prenat Diagn. 2020;40(13):1715–21.

    Article  PubMed  Google Scholar 

  34. Wexler C, Nazir N, Maloba M, et al. Programmatic evaluation of feasibility and efficiency of at birth and 6-week, point of care HIV testing in Kenyan infant. Nelson JA, organizador. PLoS One. 2020;15(10):e0240621.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Lain MG, Chicumbe S, de Araujo AR, Karajeanes E, Couto A, Giaquinto C, Vaz P. Correlates of loss to follow-up and missed diagnosis among HIV-exposed infants throughout the breastfeeding period in southern Mozambique. PLoS ONE. 2020;15(8):e0237993. https://doi.org/10.1371/journal.pone.0237993.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Sibanda E, Weller IVD, Hakim JG, Cowan FM. The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis. AIDS. 2013;27(17):2787–97.

    Article  PubMed  Google Scholar 

  37. Doherty TM, McCoy D, Donohue S. Health system constraints to optimal coverage of the prevention of mother-to-child HIV transmission programme in South Africa: lessons from the implementation of the national pilot programme. Afr Health Sci. 2005;5:213–8.

    PubMed  PubMed Central  Google Scholar 

  38. Sherman GG, Jones SA, Coovadia AH, Urban MF, Bolton KD. PMTCT from research to reality: results from routine service. S Afr Med J. 2004;94:289–92.

    CAS  PubMed  Google Scholar 

  39. Oladokun RE, Awolude O, Brown BJ, Adesina O, Oladokun A, Roberts A, et al. Service uptake and performance of the prevention of mother-to-child transmission (PMTCT) programme in Ibadan. Nigeria Afr J Med Med Sci. 2010;39:81–7.

    CAS  PubMed  Google Scholar 

  40. HHassan AS, Sakwa EM, Nabwera HM, Taegtmeyer MM, Kimutai RM, Sanders EJ. Dynamics and constraints of early infant diagnosis of HIV infection in rural Kenya. AIDS Behav. 2012;16:5–12.

    Article  Google Scholar 

  41. Ayres JRCM, Calazans GJ, Saletti Filho HC, França Junior I. Risco, vulnerabilidade e práticas de prevenção e promoção da saúde. Tratado de Saúde Coletiva, São Paulo: HUCITEC/FIOCRUZ; 2009.

  42. Kuhnt J, Vollmer S. Antenatal care services and its implications for vital and health outcomes of children: evidence from 193 surveys in 69 low-income and middle-income countries. BMJ Open. 2017;7(11):e017122.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Warri D, George A. Perceptions of pregnant women of reasons for late initiation of antenatal care: a qualitative interview study. BMC Pregnancy Childbirth. 2020;20(1):70.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Gonzalez A, Mimiaga MJ, Israel J, Andres Bedoya C, Safren SA. Substance Use Predictors of Poor Medication Adherence: The Role of Substance Use Coping Among HIV-Infected Patients in Opioid Dependence Treatment. AIDS Behav. 2017;17(1):168–73.

    Article  Google Scholar 

  45. Kerkerian G, Kestler M, Carter A, et al. Attrition Across the HIV Cascade of Care Among a Diverse Cohort of Women Living With HIV in Canada. JAIDS. 2018;79(2):226–36.

    PubMed  Google Scholar 

  46. Shokoohi M, Bauer GR, Kaida A. Patterns of social determinants of health associated with drug use among women living with HIV in Canada: a latent class analysis. Addiction. 2019;114(7):1214–24.

    Article  PubMed  PubMed Central  Google Scholar 

  47. BRASIL. Ministério da Saúde. Portaria n° 1.028, de 1° de julho de 2005. Determina que as ações que visem à redução de danos sociais e à saúde, decorrentes do uso de produtos, substâncias ou drogas que causem dependência, sejam reguladas por esta Portaria. Brasília: Ministério da Saúde; 2005.

  48. Ayon S, Jeneby F, Hamid F, Badhrus A, Abdulrahman T, Mburu G. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs. Reprod Health. 2019;16(Suppl 1):59.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Samoff E, Mobley V, Hudgins M, et al. HIV Outbreak Control With Effective Access to Care and Harm Reduction in North Carolina, 2017–2018. Am J Public Health. 2020;110(3):394–400.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Alemu YM, Habtewold TD, Alemu SM. Mother’s knowledge on prevention of mother-to-child transmission of HIV, Ethiopia: A cross sectional study. PLoS ONE. 2019;13(9):e0203043.

    Article  CAS  Google Scholar 

  51. Freeman R, Gwadz MV, Silverman E, et al. Critical race theory as a tool for understanding poor engagement along the HIV care continuum among African American/Black and Hispanic persons living with HIV in the United States: a qualitative exploration. Int J Equity in Health. 2017;16(54):1–14.

  52. Trent M, Dooley DG, Dougé J, Section on Adolescent Health, Council on Community Pediatrics and Committee on Adolescence. The impact of racism on child and adolescent health. Pediatrics. 2019;144(2):e20191765.

    Article  PubMed  Google Scholar 

  53. Aungsataporn S, Phaloprakarn C, Tangjitgamol S. Characteristics associated with loss to post-partum follow-up among adolescent mothers. J Obstet Gynaecol Res. 2019;45(5):981–6.

    Article  PubMed  Google Scholar 

  54. Yaya S, Oladimeji O, Oladimeji KE, Bishwajit G. Determinants of prenatal care use and HIV testing during pregnancy: a population-based, cross-sectional study of 7080 women of reproductive age in Mozambique. BMC Pregnancy Childbirth. 2019;19(1):354. https://doi.org/10.1186/s12884-019-2540-z Erratum.In:BMCPregnancyChildbirth.2019Nov21;19(1):436.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Ejigu Y, Tadesse B. HIV testing during pregnancy for prevention of mother-to-child transmission of HIV in Ethiopia. PLoS ONE. 2018;13(8):1–11.

    Article  CAS  Google Scholar 

  56. Cesar JA, Black RE, Buffarini R. Antenatal care in Southern Brazil: Coverage, trends and inequalities. Prev Med. 2021;145:106432.

    Article  PubMed  Google Scholar 

  57. Trindade LMM, Nogueira LMV, Rodrigues ILA, Ferreira AMR, Corrêa GM, Andrade NCO. HIV infection in pregnant women and its challenges for the prenatal care. Rev Bras Enferm. 2021;74(suppl 4):e20190784.

    Article  PubMed  Google Scholar 

  58. Monplaisir FM, Brady KA, Fekete T, Thompson DR, Roux AD, Yehia BR. Time of HIV diagnosis and engagement in prenatal care impact virologic outcomes of pregnant women with HIV. PLoS ONE. 2015;10(7):e0132262.

    Article  CAS  Google Scholar 

  59. Miranda AE, Pereira GFM, Araujo MAL, et al. Avaliação da cascata de cuidado na prevenção da transmissão vertical do HIV no Brasil. Cad Saúde Pública. 2016;32(9):1–10.

    Article  Google Scholar 

  60. Wubneh CA, Belay GM, Yehualashet FA, Tebeje NB, Mekonnen BD, Endalamaw A. Lost to Follow-up and Predictors Among HIV-Exposed Infants in Northwest Ethiopia. Infect Dis Ther. 2021;10(1):229-39. https://doi.org/10.1007/s40121-020-00360-z.

  61. Kelly-Hanku A, Nightingale CE, Pham MD, et al. Loss to follow up of pregnant women with HIV and infant HIV outcomes in the prevention of maternal to child transmission of HIV programme in two high-burden provinces in Papua New Guinea: a retrospective clinical audit. BMJ Open. 2020;10(12):e038311.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Mounier-Jack S, Mayhew SH, Mays N. Integrated care: learning between high-income, and low- and middle-income country health systems. Health Policy Plan. 2017;32(suppl 4):iv6–12.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Haskins L, Chiliza J, Barker P, et al. Evaluation of the effectiveness of a quality improvement intervention to support integration of maternal, child and HIV care in primary health care facilities in South Africa. BMC Public Health. 2020;20(3188):1–14.

    Google Scholar 

  64. BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Caderno de Atenção Básica - Atenção ao pré-natal de baixo risco. 32. ed. Brasília: Ministério da Saúde; 2013. p. 318.

  65. Hiarlaithe M, de Pee S, Bloem M. Economic and social factors are some of the most common barriers preventing women from accessing Maternal and Newborn Child Health (MNCH) and Prevention of Mother-to-Child Transmission (PMTCT) services: A literature review. AIDS Behav. 2014;18(S5):516–30.

    Article  Google Scholar 

Download references

Acknowledgements

This research was supported by a Grant from Programa Pesquisa para o SUS—PPSUS/FAPERGS/MS/CNPq/SESRS n. 03/2017.

Funding

Partial financial support was received from “Programa Pesquisa para o SUS (PPSUS/FAPERGS/MS/CNPq/SESRS n. 03/2017)”.

Author information

Authors and Affiliations

  1. Graduate Studies Program in Public Health, Federal University of Rio Grande Do Sul, Porto Alegre, RS, 90620-110, Brazil

    Karen da Silva Calvo, Mariana Alberto da Silva, Samantha Correa Vasques, Paulo Ricardo Bobek & Luciana Barcellos Teixeira

  2. Department of Social Medicine, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil

    Daniela Riva Knauth & Bruna Hentges

  3. Graduate Studies Program in Epidemiology, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil

    Daniela Riva Knauth, Bruna Hentges, Danielle Lodi Silva & Luciana Barcellos Teixeira

  4. Graduate Studies Program in Public Policy, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil

    Andrea Fachel Leal

  5. Professional Master’s in Family Health, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil

    Letícia Hamester

  6. School of Nursing, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil

    Daila Alena Raenck da Silva & Fernando Santana Fraga

  7. General Directorate of Health Surveillance, Porto Alegre, RS, Brazil

    Fernanda Vaz Dorneles

  8. Department of Public Health, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil

    Luciana Barcellos Teixeira

Authors
  1. Karen da Silva Calvo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniela Riva Knauth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bruna Hentges
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrea Fachel Leal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mariana Alberto da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Danielle Lodi Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Samantha Correa Vasques
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Letícia Hamester
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Daila Alena Raenck da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Fernanda Vaz Dorneles
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Fernando Santana Fraga
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Paulo Ricardo Bobek
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Luciana Barcellos Teixeira
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LBT and DRK conceptualized the idea. All authors contributed to the study study’s conception and design. Material preparation, data collection, and analysis were performed by LBT and KSC. The first draft of the manuscript was written by KSC, LBT, BH, and DRK. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Luciana Barcellos Teixeira.

Ethics declarations

Ethics approval and consent to participate

This study complied with the guidelines of Resolution 466/2012 of the Brazilian National Health Council. The Ethics and Research Committee of the Federal University of Rio Grande do Sul (UFRGS) and the Ethics Committee of the Municipal Government of Porto Alegre approved the study, and waived the informed consent, due to the relevance of the study whose methodology used of a municipal secondary database with a large sample.

Consent for publication

Not applicable.

Competing interests

All authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

da Silva Calvo, K., Knauth, D.R., Hentges, B. et al. Factors associated with loss to follow up among HIV-exposed children: a historical cohort study from 2000 to 2017, in Porto Alegre, Brazil. BMC Public Health 22, 1422 (2022). https://doi.org/10.1186/s12889-022-13791-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-022-13791-9

Keywords

BMC Public Health

ISSN: 1471-2458

Contact us